Atherosclerotic cardiovascular risk assessment in a 24-week, randomized, double-blind, placebo-controlled study of aldafermin

被引：0

作者：

Gunn, Nadege T. ^{[1
]}

Ling, Lei ^{[2
]}

Neff, Guy ^{[3
]}

Guy, Cynthia ^{[4
]}

Bashir, Mustafa ^{[4
]}

Paredes, Angelo ^{[5
]}

Frias, Juan ^{[6
]}

Younes, Ziad H. ^{[7
]}

Trotter, James F. ^{[8
]}

Moussa, Sam ^{[9
]}

Kohli, Anita ^{[10
]}

Connelly, Margery A. ^{[11
]}

Nelson, Kristen ^{[2
]}

Gottwald, Mildred ^{[2
]}

Chang, William ^{[2
]}

Yan, Andrew ^{[2
]}

DePaoli, Alex ^{[2
]}

Lieu, Hsiao ^{[2
]}

Harrison, Stephen ^{[12
]}

机构：

[1] Pinnacle Clin Res, Austin, TX USA

[2] NGM Biopharmaceut, San Francisco, CA USA

[3] Covenant Res & Clin, Ft Myers, FL USA

[4] Duke Univ, Durham, NC 27706 USA

[5] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA

[6] Natl Res Inst, Los Angeles, CA USA

[7] Gastro One Res, Germantown, TN USA

[8] Texas Digest Dis Consultants, Dallas, TX USA

[9] Adobe Clin Res, Tucson, AZ USA

[10] Arizona Liver Hlth, Chandler, AZ USA

[11] Labcorp, Morrisville, NC USA

[12] Pinnacle Clin Res, San Antonio, TX USA

来源：

JOURNAL OF HEPATOLOGY | 2021年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PO-1082

引用

页码：S617 / S617

页数：1

共 50 条

[31] Efficacy and Safety of Romilkimab in Diffuse Cutaneous Systemic Sclerosis (dcSSc): A Randomized, Double-Blind, Placebo-Controlled, 24-week, Proof of Concept Study
Allanore, Yannick
Denton, Christopher
Khanna, Dinesh
Soubrane, Christina
Esperet, Corinne
Marrache, Frederic
Bejuit, Raphael
Lahmar, Amel
Wung, Peter
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[32] Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension
Cefalu, William T.
Leiter, Lawrence A.
de Bruin, Tjerk W. A.
Gause-Nilsson, Ingrid
Sugg, Jennifer
Parikh, Shamik J.
DIABETES CARE, 2015, 38 (07) : 1218 - 1227
[33] A randomised, double-blind, placebo-controlled 24-week trial of aripiprazole in recently remitted bipolar I patients
Bahk, W. M.
Woo, Y. S.
Chung, M. Y.
Kim, D. H.
Yoon, B. H.
Lee, J. H.
Ahn, Y. M.
Kim, J. K.
Lee, K. H.
Min, K. J.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S482 - S482
[34] Treatment of severe Alzheimer's disease with donepezil: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S
Li, HL
McRae, T
Richardson, S
NEUROLOGY, 2006, 66 (05) : A347 - A347
[35] Donepezil treatment of severe Alzheimer's disease: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S.
Li, H.
McRae, T.
Richardson, S.
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 69 - 69
[36] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease - Pilot Study
Prasher, VP
Huxley, A
Haque, MS
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (03) : 270 - 278
[37] A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease
Alvarez, XA
Cacabelos, R
Laredo, M
Couceiro, V
Sampedro, C
Varela, M
Corzo, L
Fernandez-Novoa, L
Vargas, M
Aleixandre, M
Linares, C
Granizo, E
Muresanu, D
Moessler, H
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (01) : 43 - 54
[38] THE 24-WEEK INTERIM ANALYSIS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF ATACICEPT IN PATIENTS WITH IGA NEPHROPATHY AND PERSISTENT PROTEINURIA
Barratt, Jonathan
Tumlin, James A.
Suzuki, Yusuke
Kao, Amy
Aydemir, Aida
Zima, Yulia
Appel, Gerald
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 139 - 139
[39] A 24-Week Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of Once-Daily Umeclidinium/vilanterol 125/25 Mcg In COPD
Celli, B. R.
Crater, G.
Kilbride, S.
Mehta, R.
Tabberer, M.
Kalberg, C. J.
Church, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
[40] Donepezil improves cognitive function in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial
Pratt, RD
Perdomo, CA
NEUROLOGY, 2002, 58 (07) : A161 - A162

← 1 2 3 4 5 →